Internal Server Error

Otsuka - About the company

Otsuka is a public company based in Minato (Japan), founded in 1921 by Busaburo Otsuka. It operates as a Manufacturer of generic pharmaceuticals and nutraceuticals. Otsuka has raised an undisclosed amount in funding. The company has 1239 active competitors, including 43 funded and 337 that have exited. Its top competitors include companies like Bayer, Teva Pharmaceuticals and Wockhardt.

Company Details

Otsuka is a Japanese generic pharma company that manufactures and markets pharmaceuticals and nutraceuticals. In pharmaceuticals, the therapeutic areas it focuses on are CNS, cardiovascular, oncology, and ophthalmology. In Jan.2015, Otsuka acquired a US-based company, Avanir Pharmaceuticals. In nutraceuticals, the company sells electrolyte rehydration drinks, balanced nutrition foods, soy-based foods etc. In 2022, the company recorded annual revenues of $13.21B and a net profit of $1.02B.
Registered Address
東京都,千代田区,神田司町2丁目9番地
Key Metrics
Founded Year
1921
Location
Minato, Japan
Stage
Public
Ranked
Annual Revenue
$1B+ as on Jun 30, 2026
Employee Count
50 - 199 as on Mar 01, 2026
Investment & Acquisitions
Similar Companies
Exit Details
Public

Otsuka's IPO details

Otsuka got listed on Dec 15, 2010.
Click here to take a look at Otsuka's IPO in detail
Sign up to download Otsuka's company profile

Otsuka's funding and investors

Otsuka has raised funding over 1 round. Its latest funding round was a Grant (prize money) round on Aug 10, 2021 for $*****. 1 investor participated in its latest round. Otsuka has 2 institutional investors.

Here is the list of recent funding rounds of Otsuka:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Aug 10, 2021
4711224
Grant (prize money)
2988211
5426789
6661451
6112562
lockAccess funding benchmarks and valuations. Sign up today!

Otsuka's founders and board of directors

Founder? Claim Profile
The founders of Otsuka is Busaburo Otsuka. Tatsuo Higuchi is the CEO of Otsuka.
Here are the details of Otsuka's key team members:

Otsuka's employee count trend

Otsuka has 50 - 199 employees as of Mar 26. Here is Otsuka's employee count trend over the years:
Employee count trend for Otsuka
lockUncover Otsuka's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Otsuka's Competitors and alternates

Top competitors of Otsuka include Bayer, Teva Pharmaceuticals and Wockhardt. Here is the list of Top 10 competitors of Otsuka, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Bayer
Bayer
1863, Leverkusen (Germany), Public
Manufacturer of drugs
-
76/100
2nd
Logo for Teva Pharmaceuticals
Teva Pharmaceuticals
1901, Petah Tikva (Israel), Public
Traditional company engaged in manufacturing generics
$500M
75/100
3rd
Logo for Wockhardt
Wockhardt
1967, Mumbai (India), Public
Manufacturer of pharmaceuticals, biotechnology products, and active pharmaceutical ingredients
-
71/100
4th
Logo for Biological E
Biological E
1953, Hyderabad (India), Funding Raised
Developer of vaccines for treating multiple diseases
-
69/100
5th
Logo for Cipla
Cipla
1935, Mumbai (India), Public
Manufacturer of APIs, generic drugs, and formulation development services
-
69/100
6th
Logo for The Alvogen
The Alvogen
2009, Morristown (United States), Acquired
Developer and marketer of pharmaceutical products
$156M
69/100
7th
Logo for Emcure
Emcure
1981, Pune (India), Public
Developer, manufacturer, and markets a broad range of pharmaceutical products
$50M
68/100
8th
Logo for Amneal
Amneal
2002, Bridgewater (United States), Public
Manufacturer of generics formulations
-
68/100
9th
Logo for Laboratorio Reig Jofre
Laboratorio Reig Jofre
2000, Barcelona (Spain), Public
Manufacturer of pharmaceutical products and food supplements
-
68/100
10th
Logo for Strides Pharma Science
Strides Pharma Science
1990, Bengaluru (India), Public
Manufacturer of generic pharmaceutical products and various specialty medical formulations
-
68/100
15th
Logo for Otsuka
Otsuka
1921, Minato (Japan), Public
Manufacturer of generic pharmaceuticals and nutraceuticals
-
66/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Otsuka's competitors? Click here to see the top ones

Otsuka's Investments and acquisitions

Otsuka has made 10 investments in companies including REMARE and VIE STYLE. Otsuka has also acquired 11 companies including Visterra and ReCor Medical.
Here is the list of investments & acquisitions:lockFilter this list
Date of Investment/Acquisition
Type
Company Name
Founded Year
Location
Jul 31, 2024
Investments
2023
Matsusaka (Japan)
Mar 07, 2024
Investments
2013
Kamakura (Japan)
Mar 30, 2023
Investments
2017
Melbourne (Australia)
lockWant to know more about where corporates are investing? Sign up today!
See all investments and acquisitions by Otsuka

Reports related to Otsuka

Here is the latest report on Otsuka's geography:

News related to Otsuka

lockFilter this list
Media has covered Otsuka for a total of 32 events in the last 1 year, 14 of them have been about company updates and 1 about partnerships.
•
Otsuka and Ionis Report Positive Phase III Trial Data for FUS-ALS Therapy Ulefnersenhttps://www.clinicaltrialsarena.com/•Sep 23, 2026•Ionis, Otsuka
•
Otsuka Pharmaceutical reports expanded Phase IIIb results for Simtriyo in adult ADHDhttps://www.clinicaltrialsarena.com/•Sep 21, 2026•Otsuka
•
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Otsuka

Explore our recently published companies
  • Linzess - Boston based, Unfunded company
  • CTCBIO - Seoul based, 1993 founded, Public company
  • Apollo Generics - United Kingdom based, 2006 founded, Unfunded company
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford